Topic

Contrast Agent


AJC: More data support safety of echo contrast

Clinical Studies | Wednesday, August 11 2010
Despite black box warnings from the FDA regarding echocardiography contrast agents, studies have consistently confirmed their safety. Now, a meta-analysis published July 23 in the American Journal of Cardiology further supports that these agents do not increase incidences of either myocardial infarction (MI) or death.
 

FDA accepts Bayer's NDA for MR contrast agent, Gadovist

Regulatory News | Monday, August 09 2010
The FDA has accepted Bayer Schering Pharma's new drug application (NDA) for its gadolinium-based contrast agent for MR imaging, gadobutrol injection (Gadovist 1.0).
 

AAPM: Image-processing algorithm offers 20x less rad dose for CT

Conference News | Tuesday, July 20 2010
A new image-processing algorithm, based on the Gradient Adaptive Bilateral fIItration (GABI) algorithm, can help radiologists lower radiation dose in perfusion CT scanning, delivering as much as a 20-fold reduction with no disadvantage to perfusion information and image quality compared to a full dose image acquisition, according to a study presented at the 52nd Annual Meeting of the American Association of Physicists in Medicine (AAPM) in Philadelphia on July 20.
 

MICAD adds 17 molecular imaging, contrast agents

New Products | Tuesday, July 20 2010
The Molecular Imaging Probes and Contrast Agents Database (MICAD), created at the National Center for Biotechnology Information, National Institutes of Health via the PubMed/MedLine databases and other sources, has added 17 new agents, increasing the total to 841 agents in the database.
 

Lantheus launches Definity in India

New Products | Thursday, July 15 2010
Lantheus Medical Imaging has launched its ultrasound contrast imaging agent, Definity vial for (perflutren lipid microsphere) injectable suspension, in India.
 

Syntermed launches FDG-PET brain imaging software

New Products | Monday, July 12 2010
Syntermed launched NeuroQ version 3.5, a nuclear medicine quantitative software platform for analysis and image display of brain FDG-PET scans at the Alzheimer’s Association 2010 international conference this week in Honolulu.
 

GE's Optison re-enters U.S. market

New Products | Monday, July 12 2010
GE Healthcare Medical Diagnostics has reintroduced Optison (Perflutren Protein-Type A Microspheres Injectable Suspension), a diagnostic ultrasound contrast agent for use in select echocardiograms.
 

Siemens unveils new ultrasound technology

New Products | Thursday, July 08 2010
Siemens Healthcare has released its new ultrasound system, the Acuson S2000, a multi-specialty system for applications including general imaging, obstetrics and gynecology, as well as vascular and cardiac imaging.
 

Study: Simulation training improves contrast reaction management

Clinical Studies | Tuesday, June 29 2010
A high-fidelity simulation course for radiology residents and technologists focusing on epinephrine auto-injector use and basic life support skills during the first five minutes of a severe contrast reaction can significantly improve treatment of patients experiencing severe contrast reactions, found a recent study published online in Academic Radiology.
 

MICAD lists 824 imaging, contrast agents

Industry News | Monday, June 21 2010
The Molecular Imaging and Contrast Agent Database (MICAD), developed by the National Center for Biotechnology Information at the National Institutes of Health, has added 10 new imaging agents. The MICAD staff had created the Molecular Imaging Probes and Contrast Agents List by screening the PubMed/MedLine databases and other appropriate sources of such information and currently lists 824 agents.
 

ASE: Ultrasound therapy may dissolve intravascular thrombi

Conference News | Friday, June 11 2010
Intravenous microbubble contrast and high-pulse ultrasound may provide a non-invasive method for treating catheter-related blood clots in pediatric patients who need long term IV use, according to a study presented this week at the American Society of Echocardiography (ASE) 21st annual scientific sessions in San Diego.
 

MICAD adds 9 new agents

Industry News | Monday, May 24 2010
The Molecular Imaging and Contrast Agent Database (MICAD), developed by the National Center for Biotechnology Information at the National Institutes of Health, has uploaded nine new agents to its database.
 

Nycomed, GE form venture to sell contrast agents in Russia, CIS

Partnerships & Alliances | Tuesday, April 27 2010
GE Healthcare and Nycomed have signed an agreement to form a joint venture for the local sales, marketing and distribution of GE’s medical diagnostic contrast agents in Russia and the Commonwealth of Independent States (CIS).
 

N.Y. court allows Omniscan suit to proceed against GE

Industry News | Thursday, April 15 2010
A judge in the Supreme Court of the State of New York, County of New York has refused to throw out a lawsuit filed by a kidney patient against GE Healthcare and affiliates concerning the patient’s exposure to Omniscan, a gadolinium-based contrast agent.
 

MICAD adds 11 agents

Industry News | Tuesday, April 13 2010
The Molecular Imaging and Contrast Agent Database (MICAD) has uploaded 11 agents.
 

NAI Tech releases new speech packages, software apps

New Products | Tuesday, April 06 2010
NAI Tech Products has upgraded version of its software for the MDR Video solution, version 6.0, as well as four new MDR Video Speech Packages.
 

JIC: Ionic contrast media leads to fewer thrombus formations

Clinical Studies | Wednesday, March 24 2010
Experimental, animal and human studies have shown that the use of ionic contrast media compared with nonionic agents during PCI leads to fewer episodes of thrombus formation, according to two reviews in the March supplement of the Journal of Invasive Cardiology.
 

Toshiba introduces MRA sequence

New Products | Monday, March 22 2010
Toshiba America Medical Systems has introduced Variable True Rate Angiography with Combined Encodings (V-TRACE), an MR angiography (MRA) sequence available on Vantage Titan systems and Vantage Atlas MR systems.
 

Acist, HealthTrust ink three year deal

Contracts & Installations | Wednesday, March 10 2010
Contrast delivery developer Acist Medical Systems and HealthTrust, a healthcare group purchasing organization, have entered into a three-year contract for the company's cardiovascular injection technology.
 

ARCM: Patients prefer iohexol taste for abdominopelvic CT

Conference News | Tuesday, March 02 2010
Omnipaque (iohexol, GE Healthcare), a low osmolar iodinated contrast agent has the potential to be better tolerated by patients than the more widely used high osmolality iodinated oral contrast agent, meglumine sodium diatrizoate (Gastroview, Mallinckrodt) for CT, according to a study presented Feb.21 at the Abdominal Radiology Course Meeting held by the Society of Gastrointestinal Radiology and the Society of Uroradiology in Orlando.
 
Web Exclusives

Feature: U.S. needs national strategy to curb imaging overutilization

Medical imaging overutilization--a growing concern in the U.S.--exposes patients to unnecessary radiation, while also adding to rising healthcare costs, according to a study published online Aug. 24 in Radiology. In an interview, William R. Hendee, PhD, lead author, reviewed various methods by which medical imaging could be curtailed.

Radiology: Prelim study shows CE breast CT outperforms CT, mammo

Dedicated contrast-enhanced (CE) breast CT delivered significantly improved conspicuity of malignant breast lesions, including ductal carcinoma in situ (DCIS), compared with unenhanced breast CT and mammography, according to a study published in the September issue of Radiology.

Radiology: Rad role may evolve as image-guided biopsies trend up

CT, ultrasound and MRI have helped shift biopsy techniques away from more invasive approaches toward image-guided percutaneous techniques, according to a study published in the September issue of Radiology. The trend toward less-invasive approaches translates into enhanced safety and efficiency and could lead to more interaction between patients and radiologists.

CMS Webinar: Incentive payments to offset EHR adoption, not reimburse

The Centers for Medicare & Medicaid Services’ (CMS) EHR incentive payments are not considered reimbursement for money expended on EHR technology, but are intended to offset the cost associated with adoption and ongoing meaningful use, according to CMS during an Aug. 12 webinar.

CMS webinar: Eligible professionals can expect EHR incentives in 2011

Funding incentives for EHR use is the main goal of the Centers for Medicare & Medicaid Services' (CMS) meaningful use initiative, and there are incentive programs for both hospitals and eligible professionals, according to Elizabeth Holland, health insurance specialist at the Department of Health and Human Services, who spoke during a CMS-sponsored webinar Aug. 8.

Webinar: Stage 1 of meaningful use is for quality reporting acclimation

Stage 1 requirements for meaningful use incentives aim to strike a balance between the overall goal of EHR use and widespread adoption, while avoiding added work, said Jonathan Teich, MD, PhD, chief medical informatics officer at Elsevier Health Services, during a HIMSS webinar titled “Meaningful Use: Safety and Quality of Care.”

PORTALS

Advanced Visualization

Molecular Imaging

Integration Tools & Interoperability

More Portal Topics